1. Home
  2. GXO vs ADMA Comparison

GXO vs ADMA Comparison

Compare GXO & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GXO Logistics Inc.

GXO

GXO Logistics Inc.

HOLD

Current Price

$56.71

Market Cap

5.4B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$17.31

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GXO
ADMA
Founded
2021
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GXO
ADMA
Price
$56.71
$17.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
2
Target Price
$64.17
$28.50
AVG Volume (30 Days)
957.9K
2.2M
Earning Date
02-10-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
205.35
EPS
0.76
0.86
Revenue
$12,921,000,000.00
$488,559,000.00
Revenue This Year
$13.35
$22.13
Revenue Next Year
$6.10
$24.15
P/E Ratio
$72.33
$20.55
Revenue Growth
16.94
27.63
52 Week Low
$30.46
$13.50
52 Week High
$58.00
$25.67

Technical Indicators

Market Signals
Indicator
GXO
ADMA
Relative Strength Index (RSI) 58.51 39.66
Support Level $54.95 $16.62
Resistance Level $58.00 $18.34
Average True Range (ATR) 1.58 0.80
MACD -0.03 -0.15
Stochastic Oscillator 76.89 38.75

Price Performance

Historical Comparison
GXO
ADMA

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: